If they can do 100mln then SP can still run...NEU has revenue estimate 80mln per year and got to Market cap of 1.7bln on FDA approval...if LDX will do this it will be incredible...follow another one FDA to be soon approved BOT
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
